ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,336,185 | +303.9% | 112,101 | +364.2% | 0.01% | +150.0% |
| Q2 2023 | $578,416 | -92.7% | 24,151 | -94.2% | 0.00% | -98.3% |
| Q1 2023 | $7,890,153 | +257.5% | 419,243 | +202.4% | 0.12% | +195.0% |
| Q4 2022 | $2,206,830 | -40.0% | 138,620 | -38.3% | 0.04% | -42.9% |
| Q3 2022 | $3,675,000 | +10.7% | 224,629 | -4.6% | 0.07% | -23.1% |
| Q2 2022 | $3,319,000 | +487.4% | 235,527 | +909.0% | 0.09% | +506.7% |
| Q1 2022 | $565,000 | -62.6% | 23,342 | -64.0% | 0.02% | -68.1% |
| Q4 2021 | $1,512,000 | -23.1% | 64,775 | -45.2% | 0.05% | -16.1% |
| Q3 2021 | $1,965,000 | +324.4% | 118,276 | +522.5% | 0.06% | +250.0% |
| Q2 2021 | $463,000 | -52.8% | 19,000 | -17.1% | 0.02% | -74.6% |
| Q4 2019 | $981,000 | +111.9% | 22,930 | +78.1% | 0.06% | +133.3% |
| Q3 2019 | $463,000 | -52.4% | 12,873 | -64.6% | 0.03% | -74.8% |
| Q2 2019 | $973,000 | – | 36,400 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 27,228,338 | $611,821,000 | 5.19% |
| First Washington CORP | 176,950 | $3,976,000 | 2.06% |
| SECTORAL ASSET MANAGEMENT INC | 783,424 | $17,604,000 | 1.93% |
| HARVEY CAPITAL MANAGEMENT INC | 219,042 | $4,921,000 | 1.84% |
| Ghost Tree Capital, LLC | 400,000 | $8,988,000 | 1.82% |
| Opus Point Partners Management, LLC | 36,733 | $825,000 | 1.62% |
| Palo Alto Investors LP | 1,650,780 | $37,093,000 | 1.59% |
| EMORY UNIVERSITY | 84,714 | $1,904,000 | 1.36% |
| GARRISON BRADFORD & ASSOCIATES INC | 69,000 | $1,550,000 | 1.32% |
| HealthCor Management, L.P. | 1,378,000 | $30,964,000 | 1.05% |